MetaCap

Intercure Ltd. (INCR)

NASDAQ: INCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.24-0.27 (-7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INCR stock chart

Technical analysis

Key statistics

All statistics
Market cap
$42.03M
EPS (TTM)
-$0.95
52-week range
3.12 – 7.55
Day range
3.24 – 3.50
Volume / Avg
18.25K / 15.93K
Beta
—

52-week range

$3.12$7.55

INCR stock today

Shares of Intercure (INCR) finished lower on Nov 20 at $3.24, a drop of 7.69% or $0.27 per share, versus the S&P 500's 3.70% decline. At this level, INCR sits near the bottom of its 52-week range of $3.12 to $7.55: 57.1% below the high, set on Dec 17, 2025 and 3.8% above the low. INCR is down 28.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 50.6%.

Intercure has posted a net loss over the last twelve months (EPS of -$0.95), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Intercure

Company profile

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Alexander Rabinovich
Headquarters
Herzliya
Employees
285

Intercure peers

Health Care sector
INCR peer companies
CompanyPrice% ChgMarket capCompare
OSTXOS Therapies Incorporated0.803-2.12%$42.00Mvs INCR
BMEABiomea Fusion Inc.0.5744-2.38%$41.75Mvs INCR
CRBPCorbus Pharmaceuticals Holdings Inc.2.06-15.40%$42.45Mvs INCR
MREOMereo BioPharma Group plc ADR0.26-5.45%$41.52Mvs INCR
ELTXElicio Therapeutics Inc.1.45-3.33%$41.05Mvs INCR
SPROSpero Therapeutics Inc.0.742-10.20%$43.23Mvs INCR
TLPHTalphera Inc.0.7852+6.25%$40.80Mvs INCR
RLYBRallybio Corporation15.47-0.32%$43.32Mvs INCR

Indexes, lists and sector

Intercure stock FAQ

What is Intercure's stock price today?

INCR last traded at $3.24 as of Nov 20, 4:00 PM EST, down 7.69% on the day. Prices are delayed at least 15 minutes.

Does Intercure pay a dividend?

No. Intercure does not currently pay a regular cash dividend.

Who is Intercure's CEO?

Mr. Alexander Rabinovich is the chief executive officer of Intercure Ltd., which has about 285 employees.

Has INCR ever split its stock?

Yes. The most recent INCR stock split was a 1-for-5 split on Aug 24, 2026.

What is the INCR 52-week high?

The 52-week high for INCR is $7.55 and the 52-week low is $3.12. The stock is currently 57.1% below its high.

Compare INCR